HIV PrEp Trial in Women Halted

Preliminary data from the FEM-PrEP trial show equal numbers of HIV infection in women taking Truvada as those taking placebo. The trial has been stopped because it is highly unlikely to show that Truvada offers women protection against HIV infection.

To learn more, click here.